Title : Novel carbamate cholinesterase inhibitors that release biologically active amines following enzyme inhibition - Verheijen_2009_Bioorg.Med.Chem.Lett_19_3243 |
Author(s) : Verheijen JC , Wiig KA , Du S , Connors SL , Martin AN , Ferreira JP , Slepnev VI , Kochendorfer U |
Ref : Bioorganic & Medicinal Chemistry Lett , 19 :3243 , 2009 |
Abstract :
Conjugation of the phenol derived from rivastigmine with amphetamines gave access to novel carbamate cholinesterase inhibitors. All compounds possessed increased affinity and selectivity for AChE compared to rivastigmine and were orally bioavailable. Compound 4a, incorporating d-amphetamine, caused significant inhibition of cholinesterase in vivo at doses that were well tolerated. Release of amphetamine from 4a was demonstrated following in vitro and in vivo inhibition of cholinesterase. Compound 4a was also effective in alleviating scopolamine induced amnesia in a rat passive avoidance model. |
PubMedSearch : Verheijen_2009_Bioorg.Med.Chem.Lett_19_3243 |
PubMedID: 19423342 |
Inhibitor | CHEMBL1784957 |
Substrate | CHEMBL1784957 |
Verheijen JC, Wiig KA, Du S, Connors SL, Martin AN, Ferreira JP, Slepnev VI, Kochendorfer U (2009)
Novel carbamate cholinesterase inhibitors that release biologically active amines following enzyme inhibition
Bioorganic & Medicinal Chemistry Lett
19 :3243
Verheijen JC, Wiig KA, Du S, Connors SL, Martin AN, Ferreira JP, Slepnev VI, Kochendorfer U (2009)
Bioorganic & Medicinal Chemistry Lett
19 :3243